论文信息 - Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis

Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis

doi: 10.1111/aos.14945 a 2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDe rivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

M. Moe | Ø. K. Jørstad | R. Bragadóttir | M. S. Sivertsen | Kathrine Blom

[1] Jonathan S. Chang,et al. Face Masks and Bacterial Dispersion Toward the Periocular Area , 2021, Ophthalmology.

[2] M. Moe,et al. Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis? , 2020, Ocular immunology and inflammation.

[3] R. Ehrlich,et al. Patients Wearing Facemasks During Intravitreal Injections May Be at Higher Risk of Endophthalmitis. , 2020, Retina.

[4] M. Galdiero,et al. Current Evidence on the Ocular Surface Microbiota and Related Diseases , 2020, Microorganisms.

[5] A. McDermott. Antimicrobial compounds in tears. , 2013, Experimental eye research.